FDA Adverse Event Injury Summary report: N

EASYTRAK 2

MDR report key: 2050269 · Received April 12, 2011

Report

Report Number
2124215-2011-04670
Event Type
Injury
Date Received
April 12, 2011
Date of Event
February 18, 2011
Report Date
February 18, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
OJX
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

BOSTON SCIENTIFIC'S POST MARKET QUALITY ASSURANCE LABORATORY CANNOT CONFIRM THE OBSERVED CLINICAL OBSERVATION OF DISLODGEMENT. HOWEVER, EVIDENCE AND PAST EXPERIENCE SUGGESTS THAT LEAD DISLODGEMENT CAN BE THE RESULT OF UNIQUE PATIENT PHYSIOLOGY AND /OR IMPLANT TECHNIQUE (WHICH IS OFTEN DICTATED BY PATIENT ANATOMY). LEAD DISLODGEMENT IS A POTENTIAL COMPLICATION OF IMPLANTABLE PACING AND IS DESCRIBED IN DEVICE LABELING. THIS EVENT WILL BE RE-EVALUATED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS LEFT VENTRICULAR LEAD WAS REMOVED FROM SERVICE ONE DAY POST IMPLANT DUE TO DISLODGEMENT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 EASYTRAK 2 IMPLANTABLE LEAD OJX CPI - DEL CARIBE 4543

Patients

Seq Age Sex Outcome Treatment
1